Current management team is incompetent and unable to deliver the value the BLT science deserves.
The sooner this is resolved the better otherwise we will all loose on the potential re-rate. 25% upswing from a rock bottom MC/SP is not much to be cheering about. The BLT management team collected plenty of rewards (rewarding themselves) to date for a rather pathetic result. Outside of science, this has been very badly managed. If they were working for you, you'd dismiss them long time ago. There is nothing to suggest there is anything of substance happening behind the scenes. Such claims are made across ASX with impunity.
- Forums
- ASX - By Stock
- BLT
- Ann: HEP B PreClinical Results
Ann: HEP B PreClinical Results, page-49
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online